Alliance Pharma plc provided earnings guidance for the full year 2020. The second half of the year has started well and, whilst the global uncertainty created by COVID-19 is likely to continue for some time, based on current management forecasts and trading in the year to date, the Board expects full year results to be in line with market expectations.